Norges Bank’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-320,160
| Closed | -$25.3M | – | 683 |
|
|
2025
Q4 | $25.3M | Buy |
+320,160
| New | +$24.1M | ﹤0.01% | 1196 |
|
|
2025
Q3 | – | Sell |
-450,254
| Closed | -$17.8M | – | 763 |
|
|
2025
Q2 | $17.8M | Sell |
450,254
-407,974
| -48% | -$13.4M | ﹤0.01% | 1201 |
|
|
2025
Q1 | $25.9M | Sell |
858,228
-856,534
| -50% | -$28.1M | ﹤0.01% | 1152 |
|
|
2024
Q4 | $59.9M | Sell |
1,714,762
-312,399
| -15% | -$11.7M | 0.01% | 894 |
|
|
2024
Q3 | $81.2M | Buy |
2,027,161
+1,007,820
| +99% | +$46.9M | 0.01% | 760 |
|
|
2024
Q2 | $48.6M | Sell |
1,019,341
-217,657
| -18% | -$8.93M | 0.01% | 924 |
|
|
2024
Q1 | $53.6M | Buy |
1,236,998
+65,062
| +6% | +$3.1M | 0.01% | 906 |
|
|
2023
Q4 | $59.3M | Buy |
1,171,936
+18,010
| +2% | +$863K | 0.01% | 828 |
|
|
2023
Q3 | $52.3M | Buy |
1,153,926
+141,308
| +14% | +$5.83M | 0.01% | 815 |
|
|
2023
Q2 | $41.5M | Sell |
1,012,618
-120,073
| -11% | -$4.61M | 0.01% | 947 |
|
|
2023
Q1 | $40.5M | Sell |
1,132,691
-163,956
| -13% | -$6.16M | 0.01% | 933 |
|
|
2022
Q4 | $49M | Buy |
1,296,647
+105,896
| +9% | +$4.45M | 0.01% | 820 |
|
|
2022
Q3 | $52.7M | Buy |
1,190,751
+72,410
| +6% | +$3.05M | 0.01% | 738 |
|
|
2022
Q2 | $41.4M | Buy |
1,118,341
+332,780
| +42% | +$12.5M | 0.01% | 856 |
|
|
2022
Q1 | $29.1M | Sell |
785,561
-45,658
| -5% | -$1.49M | 0.01% | 1184 |
|
|
2021
Q4 | $25.3M | Sell |
831,219
-315,699
| -28% | -$9.94M | 0.01% | 1344 |
|
|
2021
Q3 | $38.5M | Buy |
1,146,918
+250,629
| +28% | +$9.44M | 0.01% | 1061 |
|
|
2021
Q2 | $35.8M | Buy |
896,289
+88,801
| +11% | +$3.48M | 0.01% | 1162 |
|
|
2021
Q1 | $36.3M | Buy |
807,488
+47,063
| +6% | +$2.62M | 0.01% | 1162 |
|
|
2020
Q4 | $43M | Sell |
760,425
-103,291
| -12% | -$5.15M | 0.01% | 1083 |
|
|
2020
Q3 | $41M | Sell |
863,716
-22,429
| -3% | -$1.25M | 0.01% | 947 |
|
|
2020
Q2 | $52.2M | Sell |
886,145
-179,492
| -17% | -$9.98M | 0.02% | 802 |
|
|
2020
Q1 | $50.4M | Sell |
1,065,637
-143,350
| -12% | -$7.99M | 0.02% | 698 |
|
|
2019
Q4 | $73M | Sell |
1,208,987
-186,410
| -13% | -$11.1M | 0.02% | 689 |
|
|
2019
Q3 | $83.6M | Buy |
1,395,397
+46,635
| +3% | +$3.04M | 0.03% | 593 |
|
|
2019
Q2 | $86.7M | Buy |
1,348,762
+5,986
| +0.4% | +$423K | 0.03% | 575 |
|
|
2019
Q1 | $109M | Buy |
1,342,776
+335,332
| +33% | +$21.6M | 0.04% | 467 |
|
|
2018
Q4 | $54.5M | Sell |
1,007,444
-195,645
| -16% | -$9.98M | 0.02% | 697 |
|
|
2018
Q3 | $62.1M | Buy |
1,203,089
+399,751
| +50% | +$18.8M | 0.02% | 714 |
|
|
2018
Q2 | $33.5M | Hold |
803,338
| – | – | 0.01% | 1144 |
|
|
2018
Q1 | $35.4M | Buy |
803,338
+4,967
| +0.6% | +$252K | 0.01% | 1023 |
|
|
2017
Q4 | $40.2M | Sell |
798,371
-189,755
| -19% | -$10.4M | 0.01% | 941 |
|
|
2017
Q3 | $50.1M | Buy |
988,126
+310,000
| +46% | +$16.2M | 0.02% | 771 |
|
|
2017
Q2 | $34.5M | Sell |
678,126
-37,230
| -5% | -$1.73M | 0.01% | 1014 |
|
|
2017
Q1 | $28.8M | Sell |
715,356
-350,410
| -33% | -$15.7M | 0.01% | 1126 |
|
|
2016
Q4 | $51M | Buy |
1,065,766
+193,972
| +22% | +$7.68M | 0.02% | 662 |
|
|
2016
Q3 | $30.5M | Sell |
871,794
-64,887
| -7% | -$2.03M | 0.01% | 930 |
|
|
2016
Q2 | $21.8M | Sell |
936,681
-82,555
| -8% | -$2.66M | 0.01% | 1152 |
|
|
2016
Q1 | $41.3M | Hold |
1,019,236
| – | – | 0.02% | 717 |
|
|
2015
Q4 | $63.1M | Hold |
1,019,236
| – | – | 0.03% | 517 |
|
|
2015
Q3 | $41.2M | Sell |
1,019,236
-40,344
| -4% | -$2.09M | 0.02% | 675 |
|
|
2015
Q2 | $61M | Buy |
1,059,580
+104,384
| +11% | +$6.64M | 0.03% | 563 |
|
|
2015
Q1 | $60.8M | Buy |
955,196
+74,870
| +9% | +$5.08M | 0.03% | 571 |
|
|
2014
Q4 | $54.4M | Buy |
880,326
+128,249
| +17% | +$6.33M | 0.03% | 603 |
|
|
2014
Q3 | $29.2M | Sell |
752,077
-752,077
| -50% | -$26.7M | 0.02% | 899 |
|
|
2014
Q2 | $51.8M | Buy |
1,504,154
+752,077
| +100% | +$23.7M | 0.01% | 1002 |
|
|
2014
Q1 | $32.5M | Hold |
752,077
| – | – | 0.02% | 812 |
|
|
2013
Q4 | $30M | Buy |
752,077
+25,595
| +4% | +$912K | 0.02% | 847 |
|
|
2013
Q3 | $27.3M | Buy |
726,482
+243,186
| +50% | +$7.26M | 0.02% | 898 |
|
|
2013
Q2 | $13M | Buy |
+483,296
| New | +$10.3M | 0.01% | 1311 |
|
Other funds holding IONS
VPM
VCM
Norges Bank's IONS Position: Q1 2026 in Review
Norges Bank sold out of Ionis Pharmaceuticals (IONS) in Q1 2026, closing a stake of 320,160 shares — an estimated $25.3M sold.
Norges Bank first reported a position in IONS in Q2 2013 and held it in 50 quarters. The position peaked at $109M in Q1 2019. 494 funds tracked by Wall St. Rank hold IONS as of Q1 2026.
- Norges Bank reported no remaining Ionis Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
- Norges Bank sold 320,160 Ionis Pharmaceuticals shares in Q1 2026, an estimated $25.3M.
- Norges Bank first reported a position in Ionis Pharmaceuticals in Q2 2013 and held it in 50 quarters.
- Norges Bank's Ionis Pharmaceuticals position peaked at $109M in Q1 2019.
- 494 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.
Based on Norges Bank's 13F filing for Q1 2026.